156 related articles for article (PubMed ID: 3597752)
1. Hemolytic activity and invasiveness in strains of Proteus penneri.
Rozalski A; Kotełko K
J Clin Microbiol; 1987 Jun; 25(6):1094-6. PubMed ID: 3597752
[TBL] [Abstract][Full Text] [Related]
2. [Characterization of hemolytic activity of Proteus penneri].
Rózalski A; Bartodziejska B; Wykrota M; Serwecińska L; Lukomski S; Kotełko K
Med Dosw Mikrobiol; 1993; 45(1):79-83. PubMed ID: 8231450
[TBL] [Abstract][Full Text] [Related]
3. Cell-free and cell-bound hemolytic activities of Proteus penneri determined by different Hly determinants.
Lukomski S; Serwecińska L; Rózalski A; Dziadek J; Staczek P; Jaworski A
Can J Microbiol; 1991 Jun; 37(6):419-24. PubMed ID: 1913345
[TBL] [Abstract][Full Text] [Related]
4. Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains.
Kotelko K; Kaca W; Rózalski A; Deka M
Acta Microbiol Pol; 1983; 32(4):345-51. PubMed ID: 6202102
[TBL] [Abstract][Full Text] [Related]
5. Production and properties of haemolysins from clinical isolates of the Proteeae.
Senior BW; Hughes C
J Med Microbiol; 1988 Jan; 25(1):17-25. PubMed ID: 3275780
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of hydrophobicity of Proteus vulgaris strains and ability of Proteus vulgaris and Proteus penneri strains to penetrate bladder membrane HCV T-29 cells ].
Bartodziejska B; Błaszczyk A; Wykrota M; Kwil I; Babicka D; Rózalski A
Med Dosw Mikrobiol; 2002; 54(4):335-45. PubMed ID: 12650056
[TBL] [Abstract][Full Text] [Related]
7. The simultaneous production of both Hly- and Hpm-like hemolysins is characteristic of the Proteus penneri species.
Serwecinska L; Pytlos M; Lukomski S; Jaworski A; Rózalski A
J Basic Microbiol; 1997; 37(5):361-70. PubMed ID: 9373950
[TBL] [Abstract][Full Text] [Related]
8. The production of HlyA toxin by Proteus penneri strains.
Senior BW
J Med Microbiol; 1993 Oct; 39(4):282-9. PubMed ID: 8411089
[TBL] [Abstract][Full Text] [Related]
9. Characterization of cell-bound and cell-free hemolytic activity of Proteus strains.
Kaca W; Rózalski A
Eur J Epidemiol; 1991 Mar; 7(2):159-65. PubMed ID: 2044713
[TBL] [Abstract][Full Text] [Related]
10. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli.
Koronakis V; Cross M; Senior B; Koronakis E; Hughes C
J Bacteriol; 1987 Apr; 169(4):1509-15. PubMed ID: 3549692
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of the Proteus hemolysin HpmA.
Swihart KG; Welch RA
Infect Immun; 1990 Jun; 58(6):1861-9. PubMed ID: 2341182
[TBL] [Abstract][Full Text] [Related]
12. [Proteus bacilli: features and virulence factors].
Rózalski A; Kwil I; Torzewska A; Baranowska M; Staczek P
Postepy Hig Med Dosw (Online); 2007; 61():204-19. PubMed ID: 17507868
[TBL] [Abstract][Full Text] [Related]
13. Natural antibiotic susceptibility of Proteus spp., with special reference to P. mirabilis and P. penneri strains.
Stock I
J Chemother; 2003 Feb; 15(1):12-26. PubMed ID: 12678409
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the haemolytic activity of Proteus mirabilis strains.
Peerbooms PG; Verweij AM; MacLaren DM
Antonie Van Leeuwenhoek; 1983 Apr; 49(1):1-11. PubMed ID: 6351736
[TBL] [Abstract][Full Text] [Related]
15. Proteus virulence: involvement of the pore forming alpha-hemolysin (a short review).
Tóth V; Emódy L
Acta Microbiol Immunol Hung; 2000; 47(4):457-70. PubMed ID: 11056765
[TBL] [Abstract][Full Text] [Related]
16. Structural and serological characterization of the lipopolysaccharide from Proteus penneri 20 and classification of the cross-reacting Proteus penneri strains 10, 16, 18, 20, 32 and 45 in Proteus serogroup O17.
Sidorczyk Z; Toukach FV; Zych K; Arbatsky NP; Drzewiecka D; Ziółkowski A; Shashkov AS; Knirel YA
Arch Immunol Ther Exp (Warsz); 2002; 50(5):345-50. PubMed ID: 12455869
[TBL] [Abstract][Full Text] [Related]
17. Swarming growth and resistance of Proteus penneri and Proteus vulgaris strains to normal human serum.
Kwil I; Kaźmierczak D; Różalski A
Adv Clin Exp Med; 2013; 22(2):165-75. PubMed ID: 23709372
[TBL] [Abstract][Full Text] [Related]
18. Structure of the O-polysaccharide of Proteus mirabilis O19 and reclassification of certain Proteus strains that were formerly classified in serogroup O19.
Perepelov AV; Rózalski A; Bartodziejska B; Senchenkova SN; Knirel YA
Arch Immunol Ther Exp (Warsz); 2004; 52(3):188-96. PubMed ID: 15247885
[TBL] [Abstract][Full Text] [Related]
19. Characterization and serological classification of a collection of Proteus penneri clinical strains.
Drzewiecka D; Zych K; Sidorczyk Z
Arch Immunol Ther Exp (Warsz); 2004; 52(2):121-8. PubMed ID: 15179326
[TBL] [Abstract][Full Text] [Related]
20. Immunochemical properties of Proteus penneri lipopolysaccharides--one of the major Proteus sp. virulence factors.
Palusiak A
Carbohydr Res; 2013 Oct; 380():16-22. PubMed ID: 23896159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
